{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:28:29Z","timestamp":1777591709952,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00428-014-1632-4","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T12:18:20Z","timestamp":1405945100000},"page":"587-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases"],"prefix":"10.1007","volume":"465","author":[{"given":"Pavla","family":"Vesel\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbyn\u011bk","family":"Tonar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"\u0160\u00e1lek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Vokurka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Trn\u011bn\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Kodet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojm\u00edr","family":"Moulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Ka\u0161parov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zde\u0148ka","family":"Vernerov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Velensk\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"St\u0159\u00edtesk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila","family":"Boudov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"1632_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, W\u00f6rmann B, Ludwig WD, D\u00fchrsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111:558\u2013565","journal-title":"Blood"},{"key":"1632_CR2","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","volume":"112","author":"CH Geisler","year":"2008","unstructured":"Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M, Eriksson M, Nordstr\u00f6m M, Kimby E, Boesen AM, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Akerman M, Ehinger M, Sundstr\u00f6m C, Langholm R, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E (2008) Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood 112:2687\u20132693","journal-title":"Blood"},{"key":"1632_CR3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1200920","volume":"367","author":"HC Kluin-Nelemans","year":"2012","unstructured":"Kluin-Nelemans HC, Hoster E, Hermine O, Walewski J, Trneny M, Geisler CH, Stilgenbauer S, Thieblemont C, Vehling-Kaiser U, Doorduijn JK, Coiffier B, Forstpointner R, Tilly H, Kanz L, Feugier P, Szymczyk M, Hallek M, Kremers S, Lepeu G, Sanhes L, Zijlstra JM, Bouabdallah R, Lugtenburg PJ, Macro M, Pfreundschuh M, Prochazka V, Raimondo FD, Ribrag V, Uppenkamp M, Andr\u00e9 M, Klapper W, Hiddemann W, Unterhalt M, Dreyling MH (2012) Treatment of older patients with mantle-cell lymphoma. N Engl J Med 367:520\u2013531","journal-title":"N Engl J Med"},{"key":"1632_CR4","first-page":"229","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissue","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Seto M, M\u00fcller-Hermelink HK (2008) Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissue. IARC Press, Lyon, pp 229\u2013232"},{"key":"1632_CR5","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","volume":"70","author":"V Fern\u00e1ndez","year":"2010","unstructured":"Fern\u00e1ndez V, Salamero O, Espinet B, Sol\u00e9 F, Royo C, Navarro A, Camacho F, Be\u00e1 S, Hartmann E, Amador V, Hern\u00e1ndez L, Agostinelli C, Sargent RL, Rozman M, Aymerich M, Colomer D, Villamor N, Swerdlow SH, Pileri SA, Bosch F, Piris MA, Montserrat E, Ott G, Rosenwald A, L\u00f3pez-Guillermo A, Jares P, Serrano S, Campo E (2010) Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70:1408\u20131418","journal-title":"Cancer Res"},{"key":"1632_CR6","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2009-08-236570","volume":"115","author":"CH Geisler","year":"2010","unstructured":"Geisler CH, Kolstad A, Laurell A, R\u00e4ty R, Jerkeman M, Eriksson M, Nordstr\u00f6m M, Kimby E, Boesen AM, Nilsson-Ehle H, Kuittinen O, Lauritzsen GF, Ralfkiaer E, Ehinger M, Sundstr\u00f6m C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E (2010) The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood 115:1530\u20131533","journal-title":"Blood"},{"key":"1632_CR7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3324\/haematol.2009.021113","volume":"95","author":"SA Schans van de","year":"2010","unstructured":"van de Schans SA, Janssen-Heijnen ML, Nijziel MR, Steyerberg EW, van Spronsen DJ (2010) Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting. Haematologica 95:1503\u20131509","journal-title":"Haematologica"},{"key":"1632_CR8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/10428194.2013.815349","volume":"55","author":"D Salek","year":"2014","unstructured":"Salek D, Vesela P, Boudova L, Janikova A, Klener P, Vokurka S, Jankovska M, Pytlik R, Belada D, Pirnos J, Moulis M, Kodet R, Michal M, Janousova E, Muzik J, Mayer J, Trneny M (2014) Retrospective analysis of 235 unselected patients with mantle cell lymphoma (MCL) confirms prognostic relevance of MIPI (MCL international prognostic index), and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database. Leuk Lymphoma 55:802\u2013810","journal-title":"Leuk Lymphoma"},{"key":"1632_CR9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2013.52.2466","volume":"32","author":"E Hoster","year":"2014","unstructured":"Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, van Hoof A, Trneny M, Geisler CH, Di Raimondo F, Szymczyk M, Stilgenbauer S, Thieblemont C, Hallek M, Forstpointner R, Pott C, Ribrag V, Doorduijn J, Hiddemann W, Dreyling MH, Unterhalt M (2014) Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network. J Clin Oncol 32:1338\u20131346","journal-title":"J Clin Oncol"},{"key":"1632_CR10","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood-2008-05-155507","volume":"112","author":"JJ Shah","year":"2008","unstructured":"Shah JJ, Fayad L, Romaguera J (2008) Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD. Blood 112:2583","journal-title":"Blood"},{"key":"1632_CR11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","volume":"89","author":"G Ott","year":"1997","unstructured":"Ott G, Kalla J, Ott MM, Schryen B, Katzenberger T, M\u00fcller JG, M\u00fcller-Hermelink HK (1997) Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 89:1421\u20131429","journal-title":"Blood"},{"key":"1632_CR12","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2005-10-4079","volume":"107","author":"T Katzenberger","year":"2006","unstructured":"Katzenberger T, Petzoldt C, H\u00f6ller S, M\u00e4der U, Kalla J, Adam P, Ott MM, M\u00fcller-Hermelink HK, Rosenwald A, Ott G (2006) The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood 107:3407","journal-title":"Blood"},{"key":"1632_CR13","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2007-10-117010","volume":"111","author":"O Determann","year":"2008","unstructured":"Determann O, Hoster E, Ott G, Wolfram Bernd H, Loddenkemper C, Leo Hansmann M, Barth TE, Unterhalt M, Hiddemann W, Dreyling M, Klapper W (2008) Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood 111:2385\u20132387","journal-title":"Blood"},{"key":"1632_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","volume":"2","author":"W Klapper","year":"2009","unstructured":"Klapper W, Hoster E, Determann O, Oschlies I, van der Laak J, Berger F, Bernd HW, Cabe\u00e7adas J, Campo E, Cogliatti S, Hansmann ML, Kluin PM, Kodet R, Krivolapov YA, Loddenkemper C, Stein H, M\u00f6ller P, Barth TE, M\u00fcller-Hermelink K, Rosenwald A, Ott G, Pileri S, Ralfkiaer E, Rymkiewicz G, van Krieken JH, Wacker HH, Unterhalt M, Hiddemann W, Dreyling M (2009) Ki-67 as a prognostic marker in mantle cell lymphoma\u2014consensus guidelines of the pathology panel of the European MCL Network. J Hematop 2:103\u2013111","journal-title":"J Hematop"},{"key":"1632_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/annonc\/mdn666","volume":"20","author":"J Ruan","year":"2009","unstructured":"Ruan J, Hajjar K, Rafii S, Leonard JP (2009) Angiogenesis and antiangiogenic therapy in non-Hodgkin\u2019s lymphoma. Ann Oncol 20:413\u2013424","journal-title":"Ann Oncol"},{"key":"1632_CR16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1756-8722-3-30","volume":"3","author":"L Wang","year":"2010","unstructured":"Wang L, Shi WY, Wu ZY, Varna M, Wang AH, Zhou L, Chen L, Shen ZX, Lu H, Zhao WL, Janin A (2010) Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma. J Hematol Oncol 3:30","journal-title":"J Hematol Oncol"},{"key":"1632_CR17","first-page":"904","volume":"120","author":"M Wang","year":"2012","unstructured":"Wang M, Rule SA, Martin P, Goy A, Auer R, Kahl BS, Jurczak W, Advani RH, Romaguera JE, McGreivy J, Clow F, Stevens-Brogan M, Kunkel L, Blum KA (2012) Interim results of an international, multicenter, phase 2 study of Bruton\u2019s tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), in relapsed or refractory mantle cell lymphoma (MCL): durable efficacy and tolerability with longer follow-up. ASH Annu Meet Abstr 120:904","journal-title":"ASH Annu Meet Abstr"},{"key":"1632_CR18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3324\/haematol.2011.051813","volume":"97","author":"F Zaja","year":"2012","unstructured":"Zaja F, De Luca S, Vitolo U, Orsucci L, Levis A, Salvi F, Rusconi C, Ravelli E, Tucci A, Bottelli C, Balzarotti M, Brusamolino E, Bonfichi M, Pileri SA, Sabattini E, Volpetti S, Monagheddu C, Vacca A, Ria R, Fanin R (2012) Salvage treatment with lenalidomide and dexamethasone in relapsed\/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers. Haematologica 97:416\u2013422","journal-title":"Haematologica"},{"key":"1632_CR19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.pcan.4500572","volume":"5","author":"AV Bono","year":"2002","unstructured":"Bono AV, Celato N, Cova V, Salvadore M, Chinetti S, Novario R (2002) Microvessel density in prostate carcinoma. Prostate Cancer Prostatic Dis 5:123\u2013127","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1632_CR20","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-03-1957","volume":"64","author":"B Uzzan","year":"2004","unstructured":"Uzzan B, Nicolas P, Cucherat M, Perret GY (2004) Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64:2941\u20132955","journal-title":"Cancer Res"},{"key":"1632_CR21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bmt.1704555","volume":"34","author":"S Kumar","year":"2004","unstructured":"Kumar S, Gertz MA, Dispenzieri A, Lacy MQ, Wellik LA, Fonseca R, Lust JA, Witzig TE, Kyle RA, Greipp PR, Rajkumar SV (2004) Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant 34:235\u2013239","journal-title":"Bone Marrow Transplant"},{"key":"1632_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/labinvest.3700697","volume":"88","author":"D Gratzinger","year":"2008","unstructured":"Gratzinger D, Zhao S, Tibshirani RJ, Hsi ED, Hans CP, Pohlman B, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE Jr, Lossos IS, Natkunam Y (2008) Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Lab Invest 88:38\u201347","journal-title":"Lab Invest"},{"key":"1632_CR23","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3324\/haematol.2010.037408","volume":"96","author":"TM Cardesa-Salzmann","year":"2011","unstructured":"Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, Gonz\u00e1lez-Barca E, Mercadal S, Arenillas L, Serrano S, Tubbs R, Delabie J, Gascoyne RD, Connors JM, Mate JL, Rimsza L, Braziel R, Rosenwald A, Lenz G, Wright G, Jaffe ES, Staudt L, Jares P, L\u00f3pez-Guillermo A, Campo E (2011) High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy. Haematologica 96:996\u20131001","journal-title":"Haematologica"},{"key":"1632_CR24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jcp.2006.038661","volume":"60","author":"A Tzankov","year":"2007","unstructured":"Tzankov A, Heiss S, Ebner S, Sterlacci W, Schaefer G, Augustin F, Fiegl M, Dirnhofer S (2007) Angiogenesis in nodal B cell lymphomas: a high throughput study. J Clin Pathol 60:476\u2013482","journal-title":"J Clin Pathol"},{"key":"1632_CR25","first-page":"361","volume":"9","author":"J Lasota","year":"1996","unstructured":"Lasota J, Franssila K, Koo CH, Miettinen M (1996) Molecular diagnosis of mantle cell lymphoma in paraffin-embedded tissue. Mod Pathol 9:361\u2013366","journal-title":"Mod Pathol"},{"key":"1632_CR26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jemt.20619","volume":"71","author":"Z Tonar","year":"2008","unstructured":"Tonar Z, Egger GF, Witter K, Wolfesberger B (2008) Quantification of microvessels in canine lymph nodes. Microsc Res Tech 71:760\u2013772","journal-title":"Microsc Res Tech"},{"key":"1632_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rvsc.2007.07.008","volume":"85","author":"B Wolfesberger","year":"2008","unstructured":"Wolfesberger B, Tonar Z, Witter K, Guija de Arespacohaga A, Skalicky M, Walter I, Thalhammer JG, Egger GF (2008) Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression. Res Vet Sci 85:56\u201361","journal-title":"Res Vet Sci"},{"key":"1632_CR28","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.25055","volume":"116","author":"J Ruan","year":"2010","unstructured":"Ruan J, Martin P, Coleman M, Furman RR, Cheung K, Faye A, Elstrom R, Lachs M, Hajjar KA, Leonard JP (2010) Durable responses with the metronomic regimen RT-PEPC in elderly patients with recurrent mantle cell lymphoma. Cancer 116:2655\u20132664","journal-title":"Cancer"},{"key":"1632_CR29","first-page":"66","volume":"109","author":"B Ridell","year":"2001","unstructured":"Ridell B, Norrby K (2001) Intratumoral microvascular density in malignant lymphomas of B-cell origin. AMPIS 109:66\u201372","journal-title":"AMPIS"},{"key":"1632_CR30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1078-0432.154.11.1","volume":"11","author":"A Koster","year":"2005","unstructured":"Koster A, van Krieken JH, MacKenzie MA, Schraders M, Borm GF, van der Laak JA, Leenders W, Hebeda K, Raemaekers JM (2005) Increased vascularization predicts favorable outcome in follicular lymphoma. Clin Cancer Res 11:154\u2013161","journal-title":"Clin Cancer Res"},{"key":"1632_CR31","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.ejca.2010.06.014","volume":"46","author":"M Taskinen","year":"2010","unstructured":"Taskinen M, Jantunen E, Kosma VM, Bono P, Karjalainen-Lindsberg ML, Lepp\u00e4 S (2010) Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy. Eur J Cancer 46:2506\u20132512","journal-title":"Eur J Cancer"},{"key":"1632_CR32","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"LH Argatoff","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD (1997) Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 89:2067\u20132078","journal-title":"Blood"},{"key":"1632_CR33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0609.2002.01677.x","volume":"69","author":"R R\u00e4ty","year":"2002","unstructured":"R\u00e4ty R, Franssila K, Joensuu H, Teerenhovi L, Elonen E (2002) Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol 69:11\u201320","journal-title":"Eur J Haematol"},{"key":"1632_CR34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1349-7006.2009.01433.x","volume":"101","author":"Y Kimura","year":"2010","unstructured":"Kimura Y, Sato K, Arakawa F, Karube K, Nomura Y, Shimizu K, Aoki R, Hashikawa K, Yoshida S, Kiyasu J, Takeuchi M, Nino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Kikuchi M, Ohshima K (2010) Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67. Cancer Sci 101:806\u2013814","journal-title":"Cancer Sci"},{"key":"1632_CR35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10428199609067588","volume":"21","author":"S Pittaluga","year":"1996","unstructured":"Pittaluga S, Verhoef G, Criel A, Maes A, Nuyts J, Boogaerts M, De Wolf Peeters C (1996) Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. Leuk Lymphoma 21:115\u2013125","journal-title":"Leuk Lymphoma"},{"key":"1632_CR36","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jcp.2003.013110","volume":"57","author":"MG Alexandrakis","year":"2004","unstructured":"Alexandrakis MG, Passam FH, Dambaki C, Pappa CA, Stathopoulos EN (2004) The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma. J Clin Pathol 57:856\u2013860","journal-title":"J Clin Pathol"},{"key":"1632_CR37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/annonc\/mdp495","volume":"21","author":"R Schaffel","year":"2010","unstructured":"Schaffel R, Hedvat CV, Teruya-Feldstein J, Persky D, Maragulia J, Lin D, Portlock CS, Moskowitz CH, Zelenetz AD (2010) Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma. Ann Oncol 21:133\u2013139","journal-title":"Ann Oncol"},{"key":"1632_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","volume":"131","author":"M Tiemann","year":"2005","unstructured":"Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, Berger F, Kluin P, Ott G, Pileri S, Pedrinis E, Feller AC, Merz H, Janssen D, Hansmann ML, van Krieken H, M\u00f6ller P, Stein H, Unterhalt M, Hiddemann W, Parwaresch R (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 131:29\u201338","journal-title":"Br J Haematol"},{"key":"1632_CR39","doi-asserted-by":"crossref","unstructured":"Schrader C, Meusers P, Brittinger G, Teymoortash A, Siebmann JU, Janssen D, Parwaresch R, Tiemann M (2004) Topoisomerase II\u03b1 expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome. Leukemia 18:1200\u20131206","DOI":"10.1038\/sj.leu.2403387"},{"key":"1632_CR40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2141.2010.08228.x","volume":"150","author":"JE Romaguera","year":"2010","unstructured":"Romaguera JE, Fayad LE, Feng L, Hartig K, Weaver P, Rodriguez MA, Hagemeister FB, Pro B, McLaughlin P, Younes A, Samaniego F, Goy A, Cabanillas F, Kantarjian H, Kwak L, Wang M (2010) Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate\/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma. Br J Haematol 150:200\u2013208","journal-title":"Br J Haematol"},{"key":"1632_CR41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/his.12207","volume":"63","author":"MJ Oberley","year":"2013","unstructured":"Oberley MJ, Rajguru SA, Zhang C, Kim K, Shaw GR, Grindle KM, Kahl BS, Kanugh C, Laffin J, Yang DT (2013) Immunohistochemical evaluation of MYC expression in mantle cell lymphoma. Histopathology 63:499\u2013508","journal-title":"Histopathology"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1632-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-014-1632-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1632-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T23:00:45Z","timestamp":1717110045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-014-1632-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1632"],"URL":"https:\/\/doi.org\/10.1007\/s00428-014-1632-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}